Jean‐Marie Michot

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Olivier Lambotte

Vice Dean

Université Paris-Saclay

FRANCE

View details

Aurélien Belot

Assisstant Professor in Medical Statistics

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

Giovanna Motta

Istituto Europeo di Oncologia

ITALY

View details

Felipe Prosper

SPAIN

View details

helene Moins-Teisserenc

Professor of Immunology

Université Paris Cité

FRANCE

View details

jean philippe spano

Professor

FRANCE

View details

David Sibon

Associate Professor, MD, PhD

Hôpitaux Universitaires Henri-Mondor

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jean‐Marie Michot

Research Interests

Explore related searches

Contact this professor

Articles (11)

Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome

Profile and outcome of cancer patients enrolled in contemporary phase I trials

Sequence analyses of relapsed or refractory diffuse large B‐cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH‐EP1 study

Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study

Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma

Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review

Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score

CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy

Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19

Collaborators (7)

Olivier Lambotte

Aurélien Belot

Giovanna Motta

Felipe Prosper

helene Moins-Teisserenc

jean philippe spano

David Sibon

Make your next move.